BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 994377)

  • 1. Pathophysiological response of the blood coagulation system in acute glomerulonephritis.
    Alkjaersig NK; Fletcher AP; Lewis ML; Cole BR; Ingelfinger JR; Robson AM
    Kidney Int; 1976 Oct; 10(4):319-28. PubMed ID: 994377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma fibrinolytic hyperactivity in children with acute post-streptococcal glomerulonephritis.
    Maggiore Q; Jovanovic B; Baldini G
    Nephron; 1969; 6(2):81-90. PubMed ID: 5779306
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
    Lane DA; Preston FE; VanRoss ME; Kakkar VV
    Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the evidence for activated coagulation in glomerulonephritis?
    Andrassy K; Ritz E; Mauerhoff T; Bommer J
    Am J Nephrol; 1982; 2(6):293-300. PubMed ID: 6819778
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of urinary and circulating FDP subfragments and subunits: application of the western-blot technique.
    Takahashi S; Noguchi Y; Kitagawa T
    Acta Paediatr Jpn; 1989 Apr; 31(2):127-35. PubMed ID: 2516692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary fibrin degradation products in childhood acute nephritis.
    Dawson KP
    N Z Med J; 1977 Oct; 86(597):332-4. PubMed ID: 272538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Problems of diagnosis of disseminated intravascular coagulation (DIC).
    Bowie EJ; Owen CA
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of urinary fibrin-fibrinogen degradation products (FDP) in various infantile glomerular nephorapathies].
    Tamborine G; Barbieri U; Forese S; Cocconcelli P; Zervos N
    Minerva Pediatr; 1977 Mar; 29(8):525-8. PubMed ID: 865431
    [No Abstract]   [Full Text] [Related]  

  • 9. Course and resolution of the coagulopathy in nephrotic children.
    Alkjaersig N; Fletcher AP; Narayanan M; Robson AM
    Kidney Int; 1987 Mar; 31(3):772-80. PubMed ID: 2437352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.
    Sakakibara K; Nagase M; Takada Y; Takada A
    Thromb Res; 1987 Feb; 45(4):403-11. PubMed ID: 3576523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic split products. A clinicopathological correlative study in adults with lupus glomerulonephritis and various renal diseases.
    Bond RE; Donadio JV; Holley KE; Bowie EJ
    Arch Intern Med; 1973 Aug; 132(2):182-7. PubMed ID: 4719545
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
    Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the coagulation and fibrinolysis system in pregnancy, labour and puerperium, with special reference to a possible transitory state of intravascular coagulation during labour.
    Gilabert J; Aznar J; Parrilla JJ; RegaƱon E; Vila V; Estelles A
    Thromb Haemost; 1978 Oct; 40(2):387-96. PubMed ID: 104402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary fibrinogen and fibrin fragments in children with renal disease.
    Yoshioka K; Iseki T; Akano N; Uraoka Y; Miyata H; Maki S
    Nephron; 1982; 32(2):135-9. PubMed ID: 7177290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated intravascular coagulation and the balance between blood coagulation and fibrinolysis.
    Astrup T; Jespersen J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):407-15. PubMed ID: 6083904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraglomerular deposition of coagulation-fibrinolysis factors and a platelet membrane antigen in various glomerular diseases.
    Deguchi F; Tomura S; Yoshiyama N; Takeuchi J
    Nephron; 1989; 51(3):377-83. PubMed ID: 2563903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.